Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 5l8l | ADP | Aurora kinase A | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 5l8l | ADP | Aurora kinase A | 2.7.11.1 | 1.000 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.605 | |
| 2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.583 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.537 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.532 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.528 | |
| 3efw | AK8 | Aurora kinase A | 2.7.11.1 | 0.513 | |
| 2bmc | MPY | Aurora kinase A | 2.7.11.1 | 0.509 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.499 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.493 | |
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.493 | |
| 4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.487 | |
| 5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.487 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.479 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.479 | |
| 3c4z | ADP | Rhodopsin kinase | / | 0.475 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.475 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.474 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.473 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.471 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.468 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.467 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.465 | |
| 4l9i | 8PR | Rhodopsin kinase | / | 0.464 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.463 | |
| 1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.462 | |
| 4fg8 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.460 | |
| 1jqh | ANP | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.454 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.454 | |
| 3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.453 | |
| 3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 3qc9 | ADP | Rhodopsin kinase | / | 0.449 | |
| 3w16 | P9J | Aurora kinase A | 2.7.11.1 | 0.448 | |
| 4b0g | VEK | Aurora kinase A | 2.7.11.1 | 0.447 | |
| 4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.446 | |
| 4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.444 | |
| 5ap7 | SVE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.444 | |
| 3fhy | ATP | Pyridoxal kinase | 2.7.1.35 | 0.443 | |
| 2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.441 | |
| 4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.440 |